Independent import-duty reference  /  US customs dataRates as of 11/22/2026 17:06 EST

HTS 2937 · Canada · duty record

Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones

Goods in HTS heading 2937 from Canada pay the general duty in the tariff schedule, and the rules in our table add nothing on top. Across the 29 lines below the percentage total runs from 0% to 0%. Section 232 is added to the totals only where a plain percentage applies to the line and the country (conditional and country-deal rates are listed, not added), we found no IEEPA duty in force, and antidumping duties are not checked here.

29 ten-digit lines0% to 0% percentage rangeRates as of 11/22/2026 17:06 EST2026HTSRev23
Landed-cost calculator

Selected line / duty components

2937.11.00.00
0%Total percentage

General schedule rate: Free

Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues › Somatotropin, its derivatives and structural analogues

On $10,000 customs value (percentage part): $0.00
Section 232 · conditional and country-deal rates not addedAD/CVD · none found in our listIEEPA · none found in force

Click any code in the table below to show that line here.

Duty by line

29 tariff lines · Canada

Pick your own 10-digit code from your classification or broker: the rate that applies to you is the one on your line. The last column is the percentage part only, on $10,000 of customs value.

29 lines shown

CodeProductGeneral rateAdded dutiesTotal percentageOn $10,000
Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues › Somatotropin, its derivatives and structural analoguesFreenone in our table0%$0.00
Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues › Insulin and its saltsFreenone in our table0%$0.00
Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues › OtherFreenone in our table0%$0.00
Cortisone, hydrocortisone, prednisone (dehydrocortisone), and prednisolone (dehydrohydrocortisone) › CortisoneFreenone in our table0%$0.00
Cortisone, hydrocortisone, prednisone (dehydrocortisone), and prednisolone (dehydrohydrocortisone) › HydrocortisoneFreenone in our table0%$0.00
Cortisone, hydrocortisone, prednisone (dehydrocortisone), and prednisolone (dehydrohydrocortisone) › PrednisoneFreenone in our table0%$0.00
Cortisone, hydrocortisone, prednisone (dehydrocortisone), and prednisolone (dehydrohydrocortisone) › PrednisoloneFreenone in our table0%$0.00
Halogenated derivatives of adrenal cortical hormones › Dexamethasone (INN) and its saltsFreenone in our table0%$0.00
Halogenated derivatives of adrenal cortical hormones › OtherFreenone in our table0%$0.00
Obtained directly or indirectly from animal or vegetable materials › EstrogensFreenone in our table0%$0.00
Obtained directly or indirectly from animal or vegetable materials › ProgesteroneFreenone in our table0%$0.00
Obtained directly or indirectly from animal or vegetable materials › OtherFreenone in our table0%$0.00
Estrogens and progestins › Estradiol benzoate; and Estradiol cyclopentylpropionate (Estradiol cypionate)Freenone in our table0%$0.00
Other › EstrogensFreenone in our table0%$0.00
Other › ProgesteroneFreenone in our table0%$0.00
Other › OtherFreenone in our table0%$0.00
Other › Desonide; andNandrolone phenproprionateFreenone in our table0%$0.00
Other › Salts and esters of hydrocortisoneFreenone in our table0%$0.00
Other › Salts and esters of prednisoneFreenone in our table0%$0.00
Other › Salts and esters of prednisoloneFreenone in our table0%$0.00
Other › Anabolic agents and androgensFreenone in our table0%$0.00
Other › OtherFreenone in our table0%$0.00
Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones › Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analoguesFreenone in our table0%$0.00
Catecholamine hormones, their derivatives and structural analogues › EpinephrineFreenone in our table0%$0.00
Other › Epinephrine hydrochlorideFreenone in our table0%$0.00
Other › OtherFreenone in our table0%$0.00
Amino-acid derivatives › l-Thyroxine (Levothyroxine), sodiumFreenone in our table0%$0.00
Amino-acid derivatives › OtherFreenone in our table0%$0.00
Other › OtherFreenone in our table0%$0.00

What is and is not counted

LayerStatusNote
General (column 1) duty
Included
USITC Harmonized Tariff Schedule 2026HTSRev23
Section 301
Included where a rule in our table applies
China's older lists (Lists 1, 2, 3, 4A and the 2024 four-year-review increases) are loaded by product code with the exclusions now in force; the 2026 country action is loaded by country, with set totals for the EU, Japan, South Korea, Switzerland and Taiwan. Country-specific exemption lists (USMCA goods, CAFTA-DR textiles, UK and EU lists) are not modelled. Confirm each line with a broker. USTR: Section 301 investigations · USITC Harmonized Tariff Schedule, chapter 99
Section 232
Partly included: plain-percentage rows are added, conditional and country-deal rates are shown but not added
Plain-percentage rows from the USITC chapter 99 notes are added, one row per line (vehicles and parts ahead of metals ahead of wood); conditional and country-deal rates are listed, not added. Light-vehicle parts and truck parts are both 25% and the schedule does not say whether a part on both lists pays once or twice: the site shows one. Official source: CBP: Section 232 steel and aluminum FAQs · Commerce (BIS): Section 232 investigations
IEEPA / reciprocal
Checked: none in force found
We found no IEEPA or reciprocal duty in force. The nine IEEPA tariff actions named in Executive Order 14389 were ended by it (signed 2026-02-20), and the temporary 10% Section 122 surcharge that followed was set to expire on 2026-07-24 with no extension found in the Federal Register. A Section 301 action that began on 2026-07-24 is counted in the Section 301 layer above. Canada has a separate Section 338 duty on some products; we cannot say which lines. Official source: Federal Register: Executive Order 14389, Ending Certain Tariff Actions · Federal Register: Proclamation 11012, temporary import surcharge · CBP: IEEPA tariff FAQs
Antidumping / countervailing (AD/CVD)
None found in our list
None found in our list of 757 orders; the list can miss orders newer than their first review notice. Official source: CBP: antidumping and countervailing duty · Commerce (ITA): ACCESS case search · CBP: AD/CVD case data and search · Commerce: ADCVD proceedings

Section 232: what the proclamations say about chapter 29

These are summaries of the official proclamations. Where the tariff schedule notes give a plain percentage for your line and country, it is already in the duty above (see the layer list). Rates that depend on a fact only you know (the share of metal by weight, U.S.-made metal, a country deal, a USMCA claim) are listed but not added. Check your own line against the official list or ask your broker.

Pharmaceuticals and pharmaceutical ingredients in force

  • Proclamation 11020 (2026-04-09). USITC HTS 2026HTSRev23, U.S. note 40 and headings 9903.04.60 to 9903.04.70. Patented pharmaceutical articles: total rate 100% (heading 9903.04.60); 15% total for products of Japan, the EU, South Korea, Switzerland and Liechtenstein (9903.04.62); the United Kingdom +0% (9903.04.63); +20% for companies with an approved onshoring plan (9903.04.64). Generic products, orphan drugs, nuclear medicines, plasma therapies, fertility treatments, cell and gene therapies, clinical-trial products and several other groups pay nothing extra (9903.04.61, .65 to .70).
  • Product list (added 2026-11-21): 149 code prefixes parsed from note 40(c) (chapters 29 and 30). Whether the duty applies depends on patent status and the importer, which the product code cannot show, so every row is listed and none is added to totals. The pack holds neither chapter 29 nor chapter 30, so no tariff line of the site resolves to these rows yet.

Read from the proclamation on 2026-11-21. Sources: Proclamation 11020 (Federal Register document 2026-06956)

Pending and recent notices for this heading

None of the notices we track names heading 2937 and Canada together. Many notices name only a program or a chapter, so also read all pending notices.